CDC Recommends Pfizer Booster at 5 Months
Atlanta, GA – On Tuesday, January 4th, 2022, the U.S. Centers for Disease Control and Prevention (CDC) updated their recommendation for when many people can receive a booster shot, shortening the interval from 6 months to 5 months for people who received the Pfizer-BioNTech COVID-19 Vaccine.
This means that people can now receive an mRNA booster shot 5 months after completing their Pfizer-BioNTech primary series.
Additionally, consistent with our prior recommendation for adults, CDC is recommending that moderately or severely immunocompromised 5–11-year-olds receive an additional primary dose of vaccine 28 days after their second shot. At this time, only the Pfizer-BioNTech COVID-19 vaccine is authorized and recommended for children aged 5-11.
The following is attributable to CDC Director, Dr. Rochelle Walensky:
As we have done throughout the pandemic, we will continue to update our recommendations to ensure the best possible protection for the American people. Following the FDA’s authorizations, today’s recommendations ensure people are able to get a boost of protection in the face of Omicron and increasing cases across the country, and ensure that the most vulnerable children can get an additional dose to optimize protection against COVID-19. If you or your children are eligible for a third dose or a booster, please go out and get one as soon as you can. Additionally, FDA took action this week to authorize boosters for 12-15 year olds – and I look forward to ACIP meeting on Wednesday to discuss this issue.
About the U.S. Centers for Disease Control and Prevention
The U.S. Centers for Disease Control and Prevention (CDC) works 24/7 protecting America’s health, safety and security. Whether diseases start at home or abroad, are curable or preventable, chronic or acute, or from human activity or deliberate attack, CDC responds to America’s most pressing health threats.
CDC is headquartered in Atlanta and has experts located throughout the United States and the world.